相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era
David J. Jackson et al.
THORAX (2021)
Severe asthma and bronchiectasis
Marta Garcia-Clemente et al.
JOURNAL OF ASTHMA (2020)
Relevance of TH2 Markers in the Assessment and Therapeutic Management of Severe Allergic Asthma: A Real-Life Perspective
M. Caminati et al.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2020)
Burden of asthma among patients adherent to ICS/LABA: A real-world study
Jill Davis et al.
JOURNAL OF ASTHMA (2019)
Economic impact of severe asthma in Spain: multicentre observational longitudinal study
Carlos Melero Moreno et al.
JOURNAL OF ASTHMA (2019)
Asthma control and quality of life in a real-life setting: a cross-sectional study of adult asthma patients in Japan (ACQUIRE-2)
Mitsuru Adachi et al.
JOURNAL OF ASTHMA (2019)
Treatable traits can be identified in a severe asthma registry and predict future exacerbations
Vanessa M. McDonald et al.
RESPIROLOGY (2019)
Demographic Characteristics, Comorbidities, and Exacerbation Frequency Among Patients Enrolled in the Chronicle Study: A Real-World, Prospective, Observational Study of US, Subspecialist-Treated Adults with Severe Asthma
Weily Soong et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
The prevalence and disease burden of severe eosinophilic asthma in Japan
Tadao Nagasaki et al.
JOURNAL OF ASTHMA (2019)
The Burden of Severe Asthma in France: A Case-Control Study Using a Medical Claims Database
Arnaud Bourdin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma
K. Tariq et al.
RESPIRATORY MEDICINE (2019)
Symptoms and perception of airway obstruction in asthmatic patients: Clinical implications for use of reliever medications
Peter J. Barnes et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Remotely Monitored Therapy and Nitric Oxide Suppression Identifies Nonadherence in Severe Asthma
Liam G. Heaney et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
The Severe Asthma Network in Italy: Findings and Perspectives
Enrico Heffler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)
Economic Impact and Clinical Outcomes of Omalizumab Add-On Therapy for Patients with Severe Persistent Asthma: A Real-World Study
Luis Manuel Entrenas Costa et al.
PHARMACOECONOMICS-OPEN (2019)
Lack of asthma arid rhinitis control in general practitioner-managed patients prescribed fixed-dose combination therapy in Australia
Sinthia Bosnic-Anticevich et al.
JOURNAL OF ASTHMA (2018)
Asthma control and disease burden in patients with asthma and allergic comorbidities
Lulu K. Lee et al.
JOURNAL OF ASTHMA (2018)
Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population
Marjan Kerkhof et al.
THORAX (2018)
Characterizing patients with asthma who received Global Initiative for Asthma steps 4-5 therapy and managed in a specialty care setting
Brian Stone et al.
ALLERGY AND ASTHMA PROCEEDINGS (2018)
Bronchiectasis in severe asthma Clinical features and outcomes
Isabel Coman et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
Real-world health care utilization and effectiveness of omalizumab for the treatment of severe asthma
Mina Tadrous et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)
Working while unwell: Workplace impairment in people with severe asthma
S. A. Hiles et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2018)
European Journal of Internal Medicine journal homepage: Factors reducing omalizumab response in severe asthma
B. Sposato et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study
Marc Humbert et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma
Imran Sulaiman et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Total Health-Related Costs Due to Absenteeism, Presenteeism, and Medical and Pharmaceutical Expenses in Japanese Employers
Tomohisa Nagata et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2018)
After asthma: redefining airways diseases
Ian D. Pavord et al.
LANCET (2018)
Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan
Mitsuru Adachi et al.
RESPIRATORY MEDICINE (2018)
Improving the global diagnosis and management of asthma in children
Warren Lenney et al.
THORAX (2018)
Baseline Features of the Severe Asthma Research Program (SARP III) Cohort: Differences with Age
W. Gerald Teague et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)
REAL-LIFE RETROSPECTIVE OBSERVATIONAL STUDY TO DETERMINE THE PREVALENCE AND ECONOMIC BURDEN OF SEVERE ASTHMA
A. Sicras-Mainar et al.
VALUE IN HEALTH (2018)
The North-Western Italian experience with anti IL-5 therapy amd comparison with regulatory trials
Diego Bagnasco et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2018)
Characteristics of patients with severe, uncontrolled, eosinophilic asthma enrolled in a French cohort
Michel Aubier et al.
JOURNAL OF ASTHMA AND ALLERGY (2018)
The Economic Burden of Asthma in the United States, 2008-2013
Tursynbek Nurmagambetov et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2018)
Health-related quality of life burden in severe asthma
Vanessa M. McDonald et al.
MEDICAL JOURNAL OF AUSTRALIA (2018)
Burden of systemic glucocorticoid-related complications in severe asthma
Patrick Lefebvre et al.
CURRENT MEDICAL RESEARCH AND OPINION (2017)
Improved quality of life in asthma patients under long-term therapy: Assessed by AHQ-Japan
Yuji Tohda et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2017)
Measuring the cost of poor asthma control and exacerbations
Patrick W. Sullivan et al.
JOURNAL OF ASTHMA (2017)
Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study)
Rosa Munoz-Cano et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Clinical and biological characteristics of the French COBRA cohort of adult subjects with asthma
Marina Pretolani et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
The Estimation and Inclusion of Presenteeism Costs in Applied Economic Evaluation: A Systematic Review
Jesse Kigozi et al.
VALUE IN HEALTH (2017)
The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA
Robert Y. Suruki et al.
BMC PULMONARY MEDICINE (2017)
Predicting future risk of exacerbations in Japanese patients with adult asthma: A prospective 1-year follow up study
Akihiko Tanaka et al.
ALLERGOLOGY INTERNATIONAL (2017)
The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis
Ian D. Pavord et al.
NPJ PRIMARY CARE RESPIRATORY MEDICINE (2017)
The real world effect of omalizumab add on therapy for patients with moderate to severe allergic asthma: The ASTERIX Observational study
Mohit Bhutani et al.
PLOS ONE (2017)
Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO
Bradley E. Chipps et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2017)
Characteristics of severe asthma with fungal sensitization
Katsunori Masaki et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2017)
The cost of systemic corticosteroid-induced morbidity in severe asthma: a health economic analysis
L. E. Barry et al.
RESPIRATORY RESEARCH (2017)
Effects of Age and Disease Severity on Systemic Corticosteroid Responses in Asthma
Wanda Phipatanakul et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Omalizumab Treatment Response in a Population With Severe Allergic Asthma and Overlapping COPD
Steven Maltby et al.
CHEST (2017)
Comparison of Costs and Clinical Outcomes Between Hospital and Outpatient Administration of Omalizumab in Patients With Severe Uncontrolled Asthma
Eusebi Chiner et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2016)
The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases
Mome Mukherjee et al.
BMC MEDICINE (2016)
Association Between Insomnia and Asthma Burden in the Severe Asthma Research Program (SARP) III
Faith S. Luyster et al.
CHEST (2016)
Real-life effectiveness of omalizumab in severe allergic asthma above the recommended dosing range criteria
M. Hew et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2016)
Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice in Spain
Maria del Carmen Vennera et al.
CLINICAL DRUG INVESTIGATION (2016)
Effectiveness and response predictors of omalizumab in a severe allergic asthma population with a high prevalence of comorbidities: the Australian Xolair Registry
P. G. Gibson et al.
INTERNAL MEDICINE JOURNAL (2016)
Antileukotriene Agents Versus Long-Acting Beta-Agonists in Older Adults with Persistent Asthma: A Comparison of Add-On Therapies
Shoroq M. Altawalbeh et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2016)
Effects of omalizumab in severe asthmatics across ages: A real life Italian experience
B. Sposato et al.
RESPIRATORY MEDICINE (2016)
Bronchodilator response as a marker of poor asthma control
Enrico Heffler et al.
RESPIRATORY MEDICINE (2016)
Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry
Joan Sweeney et al.
THORAX (2016)
Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study)
Robert M. Niven et al.
BMJ OPEN (2016)
Comparison of Costs and Clinical Outcomes Between Hospital and Outpatient Administration of Omalizumab in Patients With Severe Uncontrolled Asthma
Eusebi Chiner et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2016)
Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts
Michael C. Peters et al.
LANCET RESPIRATORY MEDICINE (2016)
Utilization and Costs of Severe Uncontrolled Asthma in a Managed-Care Setting
Robert S. Zeiger et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2016)
Economic Burden of Illness Among Patients with Severe Asthma in a Managed Care Setting
Benjamin Chastek et al.
Journal of Managed Care & Specialty Pharmacy (2016)
Dedicated Severe Asthma Services Improve Health-care Use and Quality of Life
David Gibeon et al.
CHEST (2015)
Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort
Dominick E. Shaw et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Characterizing the severe asthma population in the United States: claims-based analysis of three treatment cohorts in the year prior to treatment escalation
Patrick W. Sullivan et al.
JOURNAL OF ASTHMA (2015)
Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthma
David I. Bernstein et al.
JOURNAL OF ASTHMA (2015)
Misdiagnosis Among Frequent Exacerbators of Clinically Diagnosed Asthma and COPD in Absence of Confirmation of Airflow Obstruction
Vipul V. Jain et al.
LUNG (2015)
One-year outcomes of inhaled controller therapies added to systemic corticosteroids after asthma-related hospital discharge
Mohsen Sadatsafavi et al.
RESPIRATORY MEDICINE (2015)
Obstructive Sleep Apnea Risk, Asthma Burden, and Lower Airway Inflammation in Adults in the Severe Asthma Research Program (SARP) II
Mihaela Teodorescu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2015)
The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry
Stephen O'Neill et al.
THORAX (2015)
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Kian Fan Chung et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
The relationship between asthma, asthma control and economic outcomes in the United States
Patrick W. Sullivan et al.
JOURNAL OF ASTHMA (2014)
Omalizumab management beyond clinical trials: The added value of a network model
Marco Caminati et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2014)
Asthma Exacerbation Rates in Adults Are Unchanged Over a 5-Year Period Despite High-Intensity Therapy
Michael Schatz et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2014)
High Blood Eosinophil Count Is a Risk Factor for Future Asthma Exacerbations in Adult Persistent Asthma
Robert S. Zeiger et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2014)
Effectiveness of Omalizumab in Severe Allergic Asthma: A Retrospective UK Real-World Study
Neil Barnes et al.
JOURNAL OF ASTHMA (2013)
Effects of Omalizumab in Non-Atopic Asthma: Results from a Spanish Multicenter Registry
Luis Perez de Llano et al.
JOURNAL OF ASTHMA (2013)
Natural history and risk factors of obstructive changes over a 10-year period in severe asthma
Kazuto Matsunaga et al.
RESPIRATORY MEDICINE (2013)
Assessment of asthma control: The SERENA study
Antonio Corrado et al.
RESPIRATORY MEDICINE (2013)
Detection of exacerbations in asthma based on electronic diary data: results from the 1-year prospective BIOAIR study
Maciej Kupczyk et al.
THORAX (2013)
Statin use and asthma control in patients with severe asthma
Amir A. Zeki et al.
BMJ OPEN (2013)
Association Between Consistent Omalizumab Treatment and Asthma Control
Marie-Helene Lafeuille et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2013)
Impact of omalizumab on emergency-department visits, hospitalizations, and corticosteroid use among patients with uncontrolled asthma
Marie-Helene Lafeuille et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2012)
Obesity and aspirin intolerance are risk factors for difficult-to-treat asthma in Japanese non-atopic women
Y. Fukutomi et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2012)
Omalizumab versus 'Usual Care': Results from a Naturalistic Longitudinal Study in Routine Care
H. -U. Wittchen et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2012)
The relationship between combination inhaled corticosteroid and long-acting β-agonist use and severe asthma exacerbations in a diverse population
Karen E. Wells et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Omalizumab Therapy in Severe Asthma: Experience from the Spanish Registry-Some New Approaches
Maria del Carmen Vennera et al.
JOURNAL OF ASTHMA (2012)
US general population norms for telephone administration of the SF-36v2
Gregory A. Maglinte et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2012)
Real-life prospective study on asthma control in Italy: Cross-sectional phase results
Luigi Allegra et al.
RESPIRATORY MEDICINE (2012)
1-year prospective real life monitoring of asthma control and quality of life in Italy
Claudio Terzano et al.
RESPIRATORY RESEARCH (2012)
Evaluation of the asthma control test: A reliable determinant of disease stability and a predictor of future exacerbations
Fanny W. S. Ko et al.
RESPIROLOGY (2012)
Sleep quality and asthma control and quality of life in non-severe and severe asthma
Faith S. Luyster et al.
SLEEP AND BREATHING (2012)
Factors associated with health-related quality of life in adults with asthma. A cross-sectional study
Francisco-Javier Gonzalez-Barcala et al.
MULTIDISCIPLINARY RESPIRATORY MEDICINE (2012)
Effect of Switching from Salmeterol/Fluticasone to Formoterol/Budesonide Combinations in Patients with Uncontrolled Asthma
Taisuke Akamatsu et al.
ALLERGOLOGY INTERNATIONAL (2012)
Uncontrolled persistent allergic asthma in practice: eXpeRience registry baseline characteristics
Gert-Jan Braunstahl et al.
CURRENT MEDICAL RESEARCH AND OPINION (2011)
Concomitant Asthma Medication Use in Patients Receiving Omalizumab: Results from Three Large Insurance Claims Databases
Marie-Helene Lafeuille et al.
JOURNAL OF ASTHMA (2011)
Associations between fluctuations in lung function and asthma control in two populations with differing asthma severity
Cindy Thamrin et al.
THORAX (2011)
Addition of Leukotriene Receptor Antagonists to Inhaled Corticosteroids Improved QOL of Patients with Bronchial Asthma Surveyed in Suburban Tokyo, Japan
Nobuharu Ohshima et al.
ALLERGOLOGY INTERNATIONAL (2011)
Impact of asthma control on sleep, attendance at work, normal activities, and disease burden
Debra A. Wertz et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2010)
Asthma control and activity limitations: insights from the Real-world Evaluation of Asthma Control and Treatment (REACT) Study
Tmirah Haselkorn et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2010)
Factors Associated with Asthma Control in Primary Care Patients: The CHAS Study
Francisco Javier Gonzalez Barcala et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2010)
Measuring asthma control: a comparison of three classification systems
P. M. O'Byrne et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Long-acting β2-agonists in adult asthma and the pattern of risk of death and severe asthma outcomes: a study using the GPRD
F. de Vries et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Anaphylaxis epidemiology in patients with and patients without asthma: A United Kingdom database review
Antonio Gonzalez-Perez et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Factors Associated With the Control of Severe Asthma
Juan Luis Rodriguez Hermosa et al.
JOURNAL OF ASTHMA (2010)
Omalizumab reduces oral corticosteroid use in patients with severe allergic asthma: Real-life data
M. Molimard et al.
RESPIRATORY MEDICINE (2010)
Italian real-life experience of omalizumab
M. Cazzola et al.
RESPIRATORY MEDICINE (2010)
Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry
Liam G. Heaney et al.
THORAX (2010)
The Prevalence of Nonadherence in Difficult Asthma
Jacqueline Gamble et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations Standardising Endpoints for Clinical Asthma Trials and Clinical Practice
Helen K. Reddel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
A Multivariate Analysis of Risk Factors for the Air-Trapping Asthmatic Phenotype as Measured by Quantitative CT Analysis
Ashley Busacker et al.
CHEST (2009)
High-dose inhaled corticosteroids versus add-on long-acting beta-agonists in asthma: An observational study
Mike Thomas et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Phenotypic determinants of uncontrolled asthma
Valerie Siroux et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Assessing future need for acute care in adult asthmatics - The profile of asthma risk study: A prospective health maintenance organization-based study
Molly L. Osborne et al.
CHEST (2007)
Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists
M Schatz et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Costs of asthma are correlated with severity: a 1-yr prospective study
P Godard et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Interpretation of quality of life scores from the St George's Respiratory Questionnaire
M Ferrer et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Underdiagnosis of asthma: is the doctor or the patient to blame? The DIMCA project
CP van Schayck et al.
THORAX (2000)
分享论文
